A new comprehensive report detailed the latest stats and trends in hypertension, coronary heart disease, stroke and many other areas of interest. “Progress in cardiovascular health depends on knowing where we stand,” the authors wrote. “To improve, we must measure—not occasionally, but consistently, transparently and with purpose.”

The newest addition to the company's Farapulse PFA Platform was specifically approved to perform cavotricuspid isthmus ablation. 

Bayer is acquiring two cardiac amyloidosis radiotracers from Attralus, one for PET and one for SPECT. The SPECT tracer is also a theranostic agent to both image and treat amyloidosis.

The device at the heart of this transaction is the PerQseal Elite system, a fully bioabsorbable patch for percutaneous vessel closure. The technology has already gained key approvals in Europe. 

SCCT has made it a priority to help clinicians from all over the world learn more about CCTA as the modality continues to transform patient care. 

Juggling ECGs across multiple sites, devices, and departments make consistency and efficiency a daily challenge. But now there’s a better way to see everything, read everything. Philips Cardiac Workstation brings it all together in a streamlined workspace that simplifies ECG acquisition and review.

This product was distributed throughout the United States from April 2022 to December 2025. Customers have been warned to stop taking it immediately. 

According to a new wrongful death lawsuit, members of the flight crew failed to pick up on a man's stroke symptoms, resulting in significant care delays. His family is now suing for damages in excess of $50,000.

Sunil Rao, MD, told Cardiovascular Business that same-day discharge is still relatively rare for these patients, but it appears to be growing more common over time. The COVID-19 pandemic appears to have played a key role in the development of this trend.

Medtronic's MiniMed Go technology was designed to deliver real-time health data and recommendations to patients with type 1 and type 2 diabetes. It works with the Instinct sensors designed by Abbott.

Hospitals located in more competitive markets may be more likely to perform TAVR instead of SAVR, according to a new analysis of more than 130,000 patients. Is this a reason for concern?

When the devices needed for a specific procedure were not available, a group of surgeons got creative. Their one-of-a-kind approach was a success, and the patient has experienced no complications.

ASE President David Wiener detailed some of the many ways imaging societies need to adapt now that so many imagers are specializing in multiple modalities. It may be time to change how annual conferences are scheduled, for example, so that the costs of travel are easier to manage.

The FDA wants designers of goods in two health-tech categories to worry more about supplying innovative products than about pleasing the FDA. 

Previous research has shown that resistance to medical AI may be caused by difficulty in understanding both algorithms and human decision-making in healthcare.